Letters to the Editor

The clinical and biological characteristics of NUP98-KDM5A in pediatric acute myeloid leukemia

Pediatric Oncology/Hematology, Erasmus MC-Sophia Children Hospital Rotterdam, The Netherlands;
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;
Children's Oncology Group, Monrovia, California, USA;
Fred Hutchinson Cancer Research Center, Seattle, Washington, USA;
Fred Hutchinson Cancer Research Center, Seattle, Washington, USA;
Children's Oncology Group, Monrovia, California, USA;
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;
IRCCS Ospedale Bambino Gesú, Sapienza, University of Rome, Rome, Italy;
AML-BFM Study Group, Pediatric Hematology and Oncology, Essen, Germany;
University Hospital Robert Debré and Paris Diderot University, Paris, France;
CPH, University Hospital Motol and Charles University, Prague, Czech Republic;
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands;
Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, USA
Haematologica Early view May 7, 2020 https://doi.org/10.3324/haematol.2019.236745